Arcadia Biosciences, Inc. short interest in 2023
In 2023, Arcadia Biosciences, Inc.'s disclosed short interest ran from 0.48% of shares outstanding on 13 Jan 2023 to 0.75% on 29 Dec 2023, a change of +0.27 percentage points. The year's high was 4.88% on 14 Apr 2023 and its low 0.37% on 31 Jan 2023, averaging 1.17% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.53 days on 14 Apr 2023. Full history: Arcadia Biosciences, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.48% (13 Jan 2023)
- End of year
- 0.75% (29 Dec 2023)
- Change
- +0.27 pp
- High
- 4.88% (14 Apr 2023)
- Low
- 0.37% (31 Jan 2023)
- Average
- 1.17%
- Highest days to cover
- 2.53 (14 Apr 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.48% | 1.00 | |
| 31 Jan 2023 | 0.37% | 1.00 | |
| 15 Feb 2023 | 0.42% | 1.00 | |
| 28 Feb 2023 | 0.42% | 1.00 | |
| 14 Apr 2023 | 4.88% | 2.53 | 10-K filed, results (8-K) |
| 28 Apr 2023 | 4.78% | 1.46 | |
| 14 Jul 2023 | 1.94% | 1.00 | results (8-K), 10-Q filed |
| 31 Jul 2023 | 1.30% | 1.00 | results (8-K) |
| 15 Aug 2023 | 0.42% | 1.00 | 10-Q filed, results (8-K) |
| 15 Sep 2023 | 0.38% | 1.00 | |
| 29 Sep 2023 | 0.50% | 1.00 | |
| 13 Oct 2023 | 0.46% | 1.00 | |
| 31 Oct 2023 | 0.92% | 1.00 | |
| 15 Nov 2023 | 0.43% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 0.51% | 1.00 | |
| 15 Dec 2023 | 0.94% | 1.00 | |
| 29 Dec 2023 | 0.75% | 1.00 |
See also: Arcadia Biosciences, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.